Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.

Song YJ, Izumi KM, Shinners NP, Gewurz BE, Kieff E.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18448-53. doi: 10.1073/pnas.0809933105. Epub 2008 Nov 18.

2.

Epstein-Barr virus latent membrane protein 1 activates nuclear factor-kappa B in human endothelial cells and inhibits apoptosis.

Xiong A, Clarke-Katzenberg RH, Valenzuela G, Izumi KM, Millan MT.

Transplantation. 2004 Jul 15;78(1):41-9.

PMID:
15257037
3.

Epstein-Barr virus signal transduction and B-lymphocyte growth transformation.

Izumi KM.

Prog Mol Subcell Biol. 2004;36:269-88. Review.

PMID:
15171616
5.

Identification of EBV transforming genes by recombinant EBV technology.

Izumi KM.

Semin Cancer Biol. 2001 Dec;11(6):407-14. Review.

PMID:
11669602
6.

The yeast two-hybrid assay to identify interacting proteins.

Izumi KM.

Methods Mol Biol. 2001;174:249-58. No abstract available.

PMID:
11357652
8.

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

Cahir McFarland ED, Izumi KM, Mosialos G.

Oncogene. 1999 Nov 22;18(49):6959-64. Review.

9.

An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.

Kaye KM, Izumi KM, Li H, Johannsen E, Davidson D, Longnecker R, Kieff E.

J Virol. 1999 Dec;73(12):10525-30.

10.
12.

Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.

Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, Kieff E.

J Virol. 1998 Oct;72(10):7900-8.

15.

In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2).

Rochford R, Miller CL, Cannon MJ, Izumi KM, Kieff E, Longnecker R.

Arch Virol. 1997;142(4):707-20.

16.

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G.

Mol Cell Biol. 1996 Dec;16(12):7098-108.

17.

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.

Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E, Mosialos G.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11085-90.

20.

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Kaye KM, Izumi KM, Kieff E.

Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9150-4.

21.
22.
24.
25.
26.

Supplemental Content

Loading ...
Support Center